Skip to content

Clinical trials

Urinary Bladder Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Diseases Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20063
20082
20091
20102
20112
20122
20136
20143
20153
20176
20185
20193
20204
20212
20222
20231
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated10
Recruiting7
Active, not recruiting6
Unknown status3
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UroGen Pharma Ltd.4
Astellas Pharma Europe Ltd.3
Astellas Pharma Europe B.V.2
H. Lee Moffitt Cancer Center and Research Institute2
Mansoura University2
Medical Enterprises Europe B.V.2
Rainier Therapeutics2
Al-Azhar University1
Allergan1
Ambu A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Diseases61
Urinary Bladder Neoplasms30
Urologic Diseases25
Urologic Neoplasms15
Neoplasms14
Non-Muscle Invasive Bladder Neoplasms11
Urogenital Neoplasms10
Cystitis, Interstitial9
Urinary Bladder, Overactive9
Neoplasms by Site8

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.